Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional study
INTRODUCTION: As a new index of obesity and metabolism, the cardiometabolic index (CMI) has been shown to play an important role in the prediction and diagnosis of metabolic diseases. However, the relationship between CMI and osteoporosis (OP) in type 2 diabetes mellitus (T2DM) patients with metabol...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Via Medica
2025-08-01
|
| Series: | Endokrynologia Polska |
| Subjects: | |
| Online Access: | https://journals.viamedica.pl/endokrynologia_polska/article/view/105133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849230256328671232 |
|---|---|
| author | Yangyang Zhang Jinyang An Xinsai Li Lingling Li Jia Bai Haihong Lv |
| author_facet | Yangyang Zhang Jinyang An Xinsai Li Lingling Li Jia Bai Haihong Lv |
| author_sort | Yangyang Zhang |
| collection | DOAJ |
| description | INTRODUCTION: As a new index of obesity and metabolism, the cardiometabolic index (CMI) has been shown to play an important role in the prediction and diagnosis of metabolic diseases. However, the relationship between CMI and osteoporosis (OP) in type 2 diabetes mellitus (T2DM) patients with metabolism-associated fatty liver disease (MAFLD) remains unclear. The present study aims to explore the relationship between them and provide new insights for the clinical management of OP in patients with T2DM. MATERIAL AND METHODS: A total of 429 T2DM patients with MAFLD were selected. Characteristics of the participants were compared across the quartiles of CMI. Spearman correlation analysis was conducted to examine the correlation between CMI and BMD. Regression models were utilized to investigate the relationship between CMI and bone mineral density (BMD) as well as OP. Receiver operating characteristic (ROC) curves were constructed to evaluate the diagnostic efficacy of CMI for identifying OP in T2DM patients with MAFLD. RESULTS: The present study found that after adjustment for multivariate analysis, CMI was negatively correlated with lumbar spine (LS) BMD (β = –0.158, p < 0.001), femoral neck (FN) BMD (β = –0.129, p = 0.004), and hip BMD (β = –0.350, p < 0.001) in T2DM patientswith MAFLD. Furthermore, CMI was significantly associated with OP [odds ratio (OR) = 2.297, 95% confidence interval (CI): 1.198–4.424, p = 0.012]. The receiver operating characteristic curve (ROC) curve revealed that the area under the curve (AUC) of CMI for predicting OP in T2DM patients with MAFLD was 0.755 (95% CI: 0.676–0.833, p < 0.001), with an optimal threshold of 1.948. The predictive accuracy for OP was higher in female patients (AUC: 0.863, p < 0.001) compared to male patients (AUC: 0.716, p < 0.001). CONCLUSION: CMI shows a significant negative correlation with BMD in T2DM patients with MAFLD. It is an independent risk factor for OP in this patient population, offering a new direction for the prevention and screening of OP in individuals with T2DM. Moreover, CMI demonstrated greater diagnostic efficiency in postmenopausal female patients over the age of 50 years compared to male patients of the same age group. |
| format | Article |
| id | doaj-art-be5d4b6f4dfd44b2a066a964b1b34ac9 |
| institution | Kabale University |
| issn | 0423-104X 2299-8306 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Via Medica |
| record_format | Article |
| series | Endokrynologia Polska |
| spelling | doaj-art-be5d4b6f4dfd44b2a066a964b1b34ac92025-08-21T06:41:01ZengVia MedicaEndokrynologia Polska0423-104X2299-83062025-08-0176410.5603/ep.105133Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional studyYangyang Zhang0Jinyang An1Xinsai Li2Lingling Li3Jia Bai4Haihong Lv5Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, ChinaDepartment of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, ChinaDepartment of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, ChinaDepartment of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, ChinaDepartment of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, ChinaDepartment of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, ChinaINTRODUCTION: As a new index of obesity and metabolism, the cardiometabolic index (CMI) has been shown to play an important role in the prediction and diagnosis of metabolic diseases. However, the relationship between CMI and osteoporosis (OP) in type 2 diabetes mellitus (T2DM) patients with metabolism-associated fatty liver disease (MAFLD) remains unclear. The present study aims to explore the relationship between them and provide new insights for the clinical management of OP in patients with T2DM. MATERIAL AND METHODS: A total of 429 T2DM patients with MAFLD were selected. Characteristics of the participants were compared across the quartiles of CMI. Spearman correlation analysis was conducted to examine the correlation between CMI and BMD. Regression models were utilized to investigate the relationship between CMI and bone mineral density (BMD) as well as OP. Receiver operating characteristic (ROC) curves were constructed to evaluate the diagnostic efficacy of CMI for identifying OP in T2DM patients with MAFLD. RESULTS: The present study found that after adjustment for multivariate analysis, CMI was negatively correlated with lumbar spine (LS) BMD (β = –0.158, p < 0.001), femoral neck (FN) BMD (β = –0.129, p = 0.004), and hip BMD (β = –0.350, p < 0.001) in T2DM patientswith MAFLD. Furthermore, CMI was significantly associated with OP [odds ratio (OR) = 2.297, 95% confidence interval (CI): 1.198–4.424, p = 0.012]. The receiver operating characteristic curve (ROC) curve revealed that the area under the curve (AUC) of CMI for predicting OP in T2DM patients with MAFLD was 0.755 (95% CI: 0.676–0.833, p < 0.001), with an optimal threshold of 1.948. The predictive accuracy for OP was higher in female patients (AUC: 0.863, p < 0.001) compared to male patients (AUC: 0.716, p < 0.001). CONCLUSION: CMI shows a significant negative correlation with BMD in T2DM patients with MAFLD. It is an independent risk factor for OP in this patient population, offering a new direction for the prevention and screening of OP in individuals with T2DM. Moreover, CMI demonstrated greater diagnostic efficiency in postmenopausal female patients over the age of 50 years compared to male patients of the same age group.https://journals.viamedica.pl/endokrynologia_polska/article/view/105133cardiometabolic indexbone mineral densityosteoporosistype 2 diabetes mellitusmetabolism-associated fatty liver disease |
| spellingShingle | Yangyang Zhang Jinyang An Xinsai Li Lingling Li Jia Bai Haihong Lv Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional study Endokrynologia Polska cardiometabolic index bone mineral density osteoporosis type 2 diabetes mellitus metabolism-associated fatty liver disease |
| title | Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional study |
| title_full | Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional study |
| title_fullStr | Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional study |
| title_full_unstemmed | Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional study |
| title_short | Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional study |
| title_sort | cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with mafld a cross sectional study |
| topic | cardiometabolic index bone mineral density osteoporosis type 2 diabetes mellitus metabolism-associated fatty liver disease |
| url | https://journals.viamedica.pl/endokrynologia_polska/article/view/105133 |
| work_keys_str_mv | AT yangyangzhang cardiometabolicindexisanovelpredictorforosteoporosisintype2diabetesmellituspatientswithmafldacrosssectionalstudy AT jinyangan cardiometabolicindexisanovelpredictorforosteoporosisintype2diabetesmellituspatientswithmafldacrosssectionalstudy AT xinsaili cardiometabolicindexisanovelpredictorforosteoporosisintype2diabetesmellituspatientswithmafldacrosssectionalstudy AT linglingli cardiometabolicindexisanovelpredictorforosteoporosisintype2diabetesmellituspatientswithmafldacrosssectionalstudy AT jiabai cardiometabolicindexisanovelpredictorforosteoporosisintype2diabetesmellituspatientswithmafldacrosssectionalstudy AT haihonglv cardiometabolicindexisanovelpredictorforosteoporosisintype2diabetesmellituspatientswithmafldacrosssectionalstudy |